Inventor · disambiguated record
Alexander Richard Liam Cecil
Also filed as: CECIL ALEXANDER R · CECIL ALEXANDER R L · CECIL ALEXANDER RICHARD LIAM
19 granted patents·3 pending applications·105 citations·filing 2006–2021
93Inventor score
Files withKARUS THERAPEUTICS LTD14SHUTTLEWORTH STEPHEN JOSEPH3CONVALIFE SHANGHAI CO LTD2GANESAN ARASU1PACKHAM GRAHAM KEITH1
Top patents by PatentIndex Score
22 records- 0193US9200007B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsSHUTTLEWORTH STEPHEN JOSEPH·Filed 2010·Granted Dec 1, 2015·22 cites·6 claims
- 0292US11708378B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsCONVALIFE SHANGHAI CO LTD·Filed 2021·Granted Jul 25, 2023·2 cites·11 claims
- 0392US9981987B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2015·Granted May 29, 2018·11 cites·14 claims
- 0492US8981087B2Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitorsSHUTTLEWORTH STEPHEN JOSEPH·Filed 2010·Granted Mar 17, 2015·26 cites·11 claims
- 0588US10513530B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 24, 2019·5 cites·19 claims
- 0688US10501478B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 10, 2019·5 cites·7 claims
- 0786US11779586B2Compounds comprising tricyclic heterocyclic compoundsCONVALIFE SHANGHAI CO LTD·Filed 2020·Granted Oct 10, 2023·2 cites·12 claims
- 0884US10407435B2Diheteroaryl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Sep 10, 2019·6 cites·19 claims
- 0982US10377764B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Aug 13, 2019·5 cites·2 claims
- 1081US10442815B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Oct 15, 2019·5 cites·20 claims
- 1181US10150763B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 11, 2018·3 cites·16 claims
- 1280US9862685B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2014·Granted Jan 9, 2018·4 cites·12 claims
- 1379US9676765B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2013·Granted Jun 13, 2017·4 cites·8 claims
- 1470US2020354378A1Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1567US10533003B2Polyheteroarl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Jan 14, 2020·1 cites·7 claims
- 1664US8247372B2Depsipeptides and their therapeutic usePACKHAM GRAHAM KEITH·Filed 2007·Granted Aug 21, 2012·2 cites·23 claims
- 1762US10870624B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 22, 2020·0 cites·5 claims
- 1861US7977304B2FK 228 derivates as HDAC inhibitorsUNIV SOUTHAMPTON HIGHFIELD·Filed 2006·Granted Jul 12, 2011·2 cites·17 claims
- 1952US8614193B2Depsipeptides and their therapeutic useSHUTTLEWORTH STEPHEN JOSEPH·Filed 2009·Granted Dec 24, 2013·0 cites·15 claims
- 2049US2021038607A1Oxadiazolylthiophene derivatives useful as histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2145US2018235974A1Compounds comprising tricyclic heterocyclic compoundsKARUS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2237US8865655B2Depsipeptides and their therapeutic useGANESAN ARASU·Filed 2007·Granted Oct 21, 2014·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →